住院COVID-19患者急性脑血管事件研究
该回顾性观察研究分析了2020年3月15日至5月3日费城3家医院844例住院COVID-19患者的卒中发生率和机制。结果显示缺血性卒中20例(2.4%),颅内出血8例(0.9%);缺血性卒中患者80%为黑人,95%有高血压史。结论认为住院COVID-19患者急性脑血管事件风险较低,多数缺血性卒中具有传统血管危险因素和传统卒中机制。
要点
- 住院COVID-19患者缺血性卒中发生率为2.4%,颅内出血为0.9%。
- 缺血性卒中患者80%为黑人,95%有高血压史,60%有糖尿病史。
- 从COVID症状出现到卒中诊断的中位时间为21天。
核心结论
- 住院COVID-19患者急性脑血管事件风险较低。
- 多数缺血性卒中患者具有传统血管危险因素,传统卒中机制常见。
研究设计与样本
- 回顾性观察性研究,纳入2020年3月15日至5月3日费城3家医院所有住院COVID-19患者844例。
- 患者平均年龄59岁,52%为女性,68%为黑人。
主要发现
- 20例(2.4%)确诊缺血性卒中,8例(0.9%)发生颅内出血。
- 缺血性卒中患者平均年龄64岁,仅1例(5%)低于50岁,80%为黑人。
- 缺血性卒中患者中95%有高血压史,60%有糖尿病史。
- 从COVID症状出现到卒中诊断的中位时间为21天。
- 卒中机制:心源性栓塞40%,小血管病5%,其他确定机制20%,隐源性35%。
关键数值与推荐
- 11例完成血管影像的患者中,3例(27%)有大血管闭塞。
- 接受检测的患者中超过75%出现新阳性抗磷脂抗体。
- 颅内出血患者中,5/8(63%)为脑叶实质出血,3/8(38%)为蛛网膜下腔出血,4/8(50%)接受体外膜肺氧合。
临床怎么用
- 住院COVID-19患者发生急性脑血管事件的风险较低,但仍需警惕。
- 对具有传统血管危险因素(如高血压、糖尿病)的COVID-19患者应进行卒中风险评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Initial reports suggest a significant risk of thrombotic events, including stroke, in patients hospitalized with coronavirus disease 2019 (COVID-19). However, there is little systematic data on stroke incidence and mechanisms, particularly in racially diverse populations in the United States. METHODS: We performed a retrospective, observational study of stroke incidence and mechanisms in all patients with COVID-19 hospitalized from March 15 to May 3, 2020, at 3 Philadelphia hospitals. RESULTS: We identified 844 hospitalized patients with COVID-19 (mean age 59 years, 52% female, 68% Black); 20 (2.4%) had confirmed ischemic stroke; and 8 (0.9%) had intracranial hemorrhage. Of the ischemic stroke patients, mean age was 64 years, with only one patient (5%) under age 50, and 80% were Black. Conventional vascular risk factors were common, with 95% of patients having a history of hypertension and 60% a history of diabetes mellitus. Median time from onset of COVID symptoms to stroke diagnosis was 21 days. Stroke mechanism was cardioembolism in 40%, small vessel disease in 5%, other determined mechanism in 20%, and cryptogenic in 35%. Of the 11 patients with complete vascular imaging, 3 (27%) had large vessel occlusion. Newly positive antiphospholipid antibodies were present in >75% of tested patients. Of the patients with intracranial hemorrhage, 5/8 (63%) were lobar intraparenchymal hemorrhages, and 3/8 (38%) were subarachnoid hemorrhage; 4/8 (50%) were on extracorporeal membrane oxygenation. CONCLUSIONS: We found a low risk of acute cerebrovascular events in patients hospitalized with COVID-19. Most patients with ischemic stroke had conventional vascular risk factors, and traditional stroke mechanisms were common.
引用
- Rothstein A, Oldridge O, Schwennesen H, et al. Acute Cerebrovascular Events in Hospitalized COVID-19 Patients. Stroke. 2020. PMID: 32684145. doi:10.1161/STROKEAHA.120.030995
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。